Skip to main content

Breast Cancer Research

Ausgabe 6/2008

Inhalt (24 Artikel)

Review

Local control by radiotherapy: is that all there is?

Silvia C Formenti, Sandra Demaria

Open Access Research article

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer

Fabien Reyal, Martin H van Vliet, Nicola J Armstrong, Hugo M Horlings, Karin E de Visser, Marlen Kok, Andrew E Teschendorff, Stella Mook, Laura van 't Veer, Carlos Caldas, Remy J Salmon, Marc J van de Vijver, Lodewyk FA Wessels

Open Access Research article

Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation

Christian Perotti, Ruixuan Liu, Christine T Parusel, Nadine Böcher, Jörg Schultz, Peer Bork, Edith Pfitzner, Bernd Groner, Carrie S Shemanko

Review

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda

Bettina Meiser, Kathy Tucker, Michael Friedlander, Kristine Barlow-Stewart, Elizabeth Lobb, Christobel Saunders, Gillian Mitchell

Open Access Research article

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines

XingWu Zhu, Lori A Mulcahy, Rabab AA Mohammed, Andrew HS Lee, Hester A Franks, Laura Kilpatrick, Acelya Yilmazer, E Claire Paish, Ian O Ellis, Poulam M Patel, Andrew M Jackson

Editorial

Approaches towards expression profiling the response to treatment

Andrew H Sims, John MS Bartlett

Open Access Research article

ErbB3 is required for ductal morphogenesis in the mouse mammary gland

Amy J Jackson-Fisher, Gary Bellinger, Jerrica L Breindel, Fatteneh A Tavassoli, Carmen J Booth, James K Duong, David F Stern

Viewpoint

Osteopontin: a new role for a familiar actor

Nicholas IF Johnston, Mohamed K El-Tanani

Open Access Research article

A functional Notch–survivin gene signature in basal breast cancer

Connie W Lee, Karl Simin, Qin Liu, Janet Plescia, Minakshi Guha, Ashraf Khan, Chung-Cheng Hsieh, Dario C Altieri

Open Access Research article

Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies

Linda E Kelemen, Fergus J Couch, Shahana Ahmed, Alison M Dunning, Paul DP Pharoah, Douglas F Easton, Zachary S Fredericksen, Robert A Vierkant, V Shane Pankratz, Ellen L Goode, Christopher G Scott, David N Rider, Xianshu Wang, James R Cerhan, Celine M Vachon

Open Access Research article

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

Anna L Stratford, Christopher J Fry, Curtis Desilets, Alastair H Davies, Yong Y Cho, Yvonne Li, Zigang Dong, Isabelle M Berquin, Philippe P Roux, Sandra E Dunn

Open Access Research article

PAI-1 and functional blockade of SNAI1 in breast cancer cell migration

Elizabeth Fabre-Guillevin, Michel Malo, Amandine Cartier-Michaud, Hector Peinado, Gema Moreno-Bueno, Benoît Vallée, Daniel A Lawrence, José Palacios, Amparo Cano, Georgia Barlovatz-Meimon, Cécile Charrière-Bertrand

Open Access Research article

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

Bérengère Marty, Virginie Maire, Eléonore Gravier, Guillem Rigaill, Anne Vincent-Salomon, Marion Kappler, Ingrid Lebigot, Fathia Djelti, Audrey Tourdès, Pierre Gestraud, Philippe Hupé, Emmanuel Barillot, Francisco Cruzalegui, Gordon C Tucker, Marc-Henri Stern, Jean-Paul Thiery, John A Hickman, Thierry Dubois

Open Access Research article

Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study

Thomas P Ahern, Timothy L Lash, Henrik T Sørensen, Lars Pedersen

Open Access Research article

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells

Annabel C Borley, Stephen Hiscox, Julia Gee, Chris Smith, Victoria Shaw, Peter Barrett-Lee, Robert I Nicholson

Review

Eph receptors in breast cancer: roles in tumor promotion and tumor suppression

David Vaught, Dana M Brantley-Sieders, Jin Chen

Open Access Research article

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Joan S Lewis-Wambi, Helen R Kim, Chris Wambi, Roshani Patel, Jennifer R Pyle, Andres J Klein-Szanto, V Craig Jordan

Open Access Research article

Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype

Changhua Zhou, Ashley M Nitschke, Wei Xiong, Qiang Zhang, Yan Tang, Michael Bloch, Steven Elliott, Yun Zhu, Lindsey Bazzone, David Yu, Christopher B Weldon, Rachel Schiff, John A McLachlan, Barbara S Beckman, Thomas E Wiese, Kenneth P Nephew, Bin Shan, Matthew E Burow, Guangdi Wang

Open Access Research article

Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide

Kannan Krishnamurthy, Guanghu Wang, Dmitriy Rokhfeld, Erhard Bieberich

Open Access Research article

The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer

Chantal C Orgéas, Per Hall, Lena U Rosenberg, Kamila Czene

Open Access Research article

The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer

William Tapper, Victoria Hammond, Sue Gerty, Sarah Ennis, Peter Simmonds, Andrew Collins, Diana Eccles

Open Access Research article

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Alexandra M Pietersen, Hugo M Horlings, Michael Hauptmann, Anita Langerød, Abderrahim Ajouaou, Paulien Cornelissen-Steijger, Lodewijk F Wessels, Jos Jonkers, Marc J van de Vijver, Maarten van Lohuizen

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.